Lidocaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/22/2012.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-4283-01
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)
- Initial Posting
- 02/22/2012
- Revised Date